Category: Align Technology Inc.
An International Trade Commission judge finds that Pakistani dental device maker ClearCorrect infringes 7 Align Technology patents.
Align Technology (NSDQ:ALGN) said a judge with the International Trade Commission found that Pakistani dental device maker ClearCorrect and a U.S. affiliate infringe 7 of Align's patents.
Dental devices maker Align Technologies gains almost 5% on Wall Street after reporting adjusted per-share earnings about 30% higher than analysts' expectations.
Align Technology (NSDQ:ALGN) got a big Wall Street boost today after reporting a big increase in sales and strong growth in shipments of its flagship Invisalign product.
Align Technology got an 8.5% boost on Wall Street today after the company released its Q4 2012 earnings report, beating analysts' estimates with record Invisalign shipments during the year.
Orthodontic devices maker Align Technology (NSDQ:ALGN) won big points on Wall Street today after releasing a strong 4th quarter earnings report, beating expectations and issuing optimistic projections for 2013.
MassDevice.com looks back at the voices, which made headlines in the medical device industry in 2012
"We play a critical role in managing and moving market share. I think the device sector has not necessarily acknowledged the role of the GPOs, but I think increasingly, as products mature in particular, GPOs play a vital role in helping to drive market share up on behalf of a supplier." -- Novation CEO Jody Hatcher
The MassDevice Big 100 West, a conversation of medical device company leaders, in pictures.
MassDevice held its 2nd annual Big 100 Roundtable West event in Newport Beach, Calif., December 11. A group of nearly med-tech executives and stakeholders gathered for an evening of networking, insight into medical device marketing and intimate interviews with David Pyott, CEO of Allergan; Tom Prescott, CEO of Align Technology; James Mazzo, president of Abbott Medical Optics; and Robert Grant, chairman and Strathspey Crown.
Abbott Medical Optics president James Mazzo with CHI co-founder David Gollaher.